Concepedia

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

Hatsuo Maeda, Seiji Hori, Hiroshi Ohizumi, Takahiro Segawa, Yoshiyuki Kakehi, Osamu Ogawa, Akira Kakizuka

Cell Death and Differentiation · 2004 · 180 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood · 1997 · 1.4K citations

Superoxide dismutase as a target for the selective killing of cancer cells

Peng Huang, Feng Li, Eli Oldham et al. · Nature · 2000 · 837 citations

, , +11

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Guoqiang Chen, Xuegeng Shi, Wei Tang et al. · PubMed · 1997 · 802 citations

Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway

Yongkui Jing, Jie Dai, Ruth M.E. Chalmers-Redman et al. · Blood · 1999 · 532 citations

Use of arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) in the treatment of patients with acute promyelocytic leukemia

Guillermo Lazo, Hagop M. Kantarjian, Elihu H. Estey et al. · Cancer · 2003 · 495 citations